幹細胞治療の世界市場:自己幹細胞治療、アロジェネイック幹細胞治療

◆英語タイトル:Stem Cell Therapy - Global Market Outlook (2015-2022)
◆商品コード:SMRC60799
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年5月11日
◆ページ数:139
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥460,650見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥582,750見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

According to Stratistics MRC, the stem cell therapy market is expected to grow at a CAGR of 37.6% during the forecast period 2015 to 2022. Rising awareness about stem cell therapies is the key factor driving the market growth. Furthermore, rising prevalence of chronic diseases, increasing approvals of clinical trials for stem cells therapy, increasing funds from government and private organizations, technological advancements and rising focus towards human embryonic stem cells are some of the drivers fuelling the market growth. However, complications in preservation of stem cells and lack of required infrastructures are the restraints hampering the market growth. Evolution of new therapies and low regulatory frameworks in emerging regions are expected to provide opportunities for market growth over the forecast period.
North America is expected to account for the largest share of the global market over the forecast period due to advancements in stem cell therapy and continuous R & D activities on stem cells. Whereas, Asia Pacific is likely to witness highest growth on account of favourable government policies, increasing adoption of stem cell therapy and rising population in China and India.

Some of the key players in stem cell therapy market include Aastrom Biosciences Inc., Cellular Dynamics International Inc., ReNeuron Group plc, Roslin Cells limited, Advanced Cell Technologies Inc., Cytori Therapeutics Inc., Celgene Corporation, Gamida Cell Ltd., International Stem Cell Corp., Mesoblast Ltd., Pluristem Therapeutics Inc., Fibrocell Science Inc., Stemcells Inc., Regeneus Ltd and Athersys Inc.

Treatments Covered:
• Autologous stem cell therapy
o CNS Diseases
o Wounds and Injuries
o CVS Diseases
o Musculoskeletal Disorders
o GIT Diseases
o Other Diseases
• Allogeneic stem cell therapy
o CNS Diseases
o Musculoskeletal Disorders
o Wounds and Injuries
o GIT diseases
o Metabolic Diseases
o Immune System Diseases
o Eye Diseases
o CVS Diseases
o Other Diseases

End Users Covered:
• Hospitals
• Ambulatory Surgical Centers

Applications Covered:
• Cardiovascular diseases
• Eye diseases
• Metabolic diseases
• Musculoskeletal disorders
• Gastro intestine diseases
• Central Nervous System diseases
• Immune system diseases
• Wounds and injuries
• Other diseases

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancement

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Application Analysis
3.8 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Stem Cell Therapy Market, By Treatment
5.1 Introduction
5.2 Autologous stem cell therapy
5.2.1 CNS Diseases
5.2.2 Wounds and Injuries
5.2.3 CVS Diseases
5.2.4 Musculoskeletal Disorders
5.2.5 GIT Diseases
5.2.6 Other Diseases
5.3 Allogeneic stem cell therapy
5.3.1 CNS Diseases
5.3.2 Musculoskeletal Disorders
5.3.3 Wounds and Injuries
5.3.4 GIT diseases
5.3.5 Metabolic Diseases
5.3.6 Immune System Diseases
5.3.7 Eye Diseases
5.3.8 CVS Diseases
5.3.9 Other Diseases

6 Global Stem Cell Therapy Market, By End User
6.1 Introduction
6.2 Hospitals
6.3 Ambulatory Surgical centers

7 Global Stem Cell Therapy Market, By Application
7.1 Introduction
7.2 Cardiovascular diseases
7.3 Eye diseases
7.4 Metabolic diseases
7.5 Musculoskeletal disorders
7.6 Gastro intestine diseases
7.7 Central Nervous System diseases
7.8 Immune system diseases
7.9 Wounds and injuries
8.10 Other diseases

8 Global Stem Cell Therapy Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Aastrom Biosciences Inc.
10.2 Cellular Dynamics International Inc.
10.3 ReNeuron Group plc
10.4 Roslin Cells limited
10.5 Advanced Cell Technologies Inc.
10.6 Cytori Therapeutics Inc.
10.7 Celgene Corporation
10.8 Gamida Cell Ltd.
10.9 International Stem Cell Corporation
10.10 Mesoblast Ltd.
10.11 Pluristem Therapeutics Inc.
10.12 Fibrocell Science Inc.
10.13 Stemcells Inc.
10.14 Regeneus Ltd
10.15 Athersys Inc.

List of Tables
1 Global Stem Cell Therapy Market Outlook, By Region (2013-2022) ($MN)
2 Global Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
3 Global Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
4 Global Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
5 Global Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
6 Global Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
7 Global Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
8 Global Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
9 Global Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
10 Global Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
11 Global Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
12 Global Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
13 Global Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
14 Global Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
15 Global Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
16 Global Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
17 Global Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
18 Global Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
19 Global Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
20 Global Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
21 Global Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
22 Global Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
23 Global Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
24 Global Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
25 Global Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
26 Global Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
27 Global Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
28 Global Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
29 Global Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
30 Global Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
31 Global Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
32 Global Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
33 Global Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
34 North America Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
35 North America Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
36 North America Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
37 North America Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
38 North America Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
39 North America Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
40 North America Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
41 North America Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
42 North America Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
43 North America Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
44 North America Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
45 North America Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
46 North America Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
47 North America Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
48 North America Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
49 North America Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
50 North America Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
51 North America Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
52 North America Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
53 North America Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
54 North America Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
55 North America Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
56 North America Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
57 North America Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
58 North America Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
59 North America Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
60 North America Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
61 North America Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
62 North America Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
63 North America Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
64 North America Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
65 North America Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
66 North America Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
67 Europe Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
68 Europe Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
69 Europe Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
70 Europe Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
71 Europe Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
72 Europe Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
73 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
74 Europe Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
75 Europe Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
76 Europe Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
77 Europe Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
78 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
79 Europe Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
80 Europe Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
81 Europe Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
82 Europe Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
83 Europe Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
84 Europe Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
85 Europe Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
86 Europe Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
87 Europe Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
88 Europe Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
89 Europe Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
90 Europe Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
91 Europe Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
92 Europe Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
93 Europe Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
94 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
95 Europe Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
96 Europe Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
97 Europe Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
98 Europe Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
99 Europe Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
100 Asia Pacific Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
101 Asia Pacific Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
102 Asia Pacific Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
103 Asia Pacific Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
104 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
105 Asia Pacific Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
106 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
107 Asia Pacific Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
108 Asia Pacific Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
109 Asia Pacific Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
110 Asia Pacific Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
111 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
112 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
113 Asia Pacific Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
114 Asia Pacific Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
115 Asia Pacific Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
116 Asia Pacific Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
117 Asia Pacific Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
118 Asia Pacific Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
119 Asia Pacific Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
120 Asia Pacific Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
121 Asia Pacific Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
122 Asia Pacific Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
123 Asia Pacific Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
124 Asia Pacific Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
125 Asia Pacific Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
126 Asia Pacific Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
127 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
128 Asia Pacific Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
129 Asia Pacific Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
130 Asia Pacific Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
131 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
132 Asia Pacific Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
133 RoW Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
134 RoW Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
135 RoW Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
136 RoW Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
137 RoW Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
138 RoW Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
139 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
140 RoW Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
141 RoW Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
142 RoW Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
143 RoW Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
144 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
145 RoW Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
146 RoW Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
147 RoW Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
148 RoW Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
149 RoW Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
150 RoW Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
151 RoW Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
152 RoW Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
153 RoW Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
154 RoW Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
155 RoW Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
156 RoW Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
157 RoW Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
158 RoW Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
159 RoW Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
160 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
161 RoW Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
162 RoW Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
163 RoW Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
164 RoW Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
165 RoW Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)



【レポートのキーワード】

幹細胞治療、自己幹細胞治療、アロジェネイック幹細胞治療、医療

★調査レポート[幹細胞治療の世界市場:自己幹細胞治療、アロジェネイック幹細胞治療]販売に関する免責事項
★調査レポート[幹細胞治療の世界市場:自己幹細胞治療、アロジェネイック幹細胞治療]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆